Eucomed urges new thinking in light regulatory merger:
This article was originally published in Clinica
Executive Summary
Europe's largest medical device trade association, Eucomed, has responded to the news that the UK's Medical Devices Agency is to merge with the Medicines Control Agency by calling for some rethinking of the traditional regulatory basis (see this issues, pp 3-4). All European health authorities should "develop a new approach for the growing variety of emerging medical technologies that elude the traditional drugs-device divide", it advocates. The association says that it hopes the new measures in the UK will open the door to a new thinking that goes beyond the distinction between medical devices and pharmaceuticals.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.